28,184 press releases indexed
All general 8852technology 8550health 2615finance 1971consumer 1605energy 1469education 735realestate 630entertainment 502government 432startup 420automotive 291agriculture 112
health prnewswire_all 5/18/2026
EyePromise Introduces Heyedrate Clinical, Gamechanger in Dry Eye Hydration

EyePromise Introduces Heyedrate Clinical, Gamechanger in Dry Eye Hydration

health prnewswire_all 5/18/2026
OMNY Health Surpasses 175 Million Patient Milestone; Launches Oncology Product Suite to Solve Complex Real-World Evidence Gaps

OMNY Health Surpasses 175 Million Patient Milestone; Launches Oncology Product Suite to Solve Complex Real-World Evidence Gaps

wecharge.in
health prnewswire_all 5/18/2026
IBRX 8-DAY DEADLINE ALERT: ImmunityBio (IBRX) Investors Face Losses Amid FDA Warning Regarding Unsupported Cancer Treatment Claims -- Hagens Berman

IBRX 8-DAY DEADLINE ALERT: ImmunityBio (IBRX) Investors Face Losses Amid FDA Warning Regarding Unsupported Cancer Treatment Claims -- Hagens Berman

health prnewswire_all 5/18/2026
PorTal Access, Inc. Announces Completion of FDA 510(k) Submission for Flexi-Port™, Marking Major Milestone Toward Commercial Launch

PorTal Access, Inc. Announces Completion of FDA 510(k) Submission for Flexi-Port™, Marking Major Milestone Toward Commercial Launch

health prnewswire_all 5/18/2026
Galvanize Therapeutics Receives FDA Clearance for Aliya EX Generator, Expanding its Aliya Pulsed Electric Field Portfolio for Surgical Ablation of Soft Tissue

Galvanize Therapeutics Receives FDA Clearance for Aliya EX Generator, Expanding its Aliya Pulsed Electric Field Portfolio for Surgical Ablation of Soft Tissue

health prnewswire_all 5/18/2026
PFF Registry Soars Past 3,000 Enrollees for Lifesaving Research

PFF Registry Soars Past 3,000 Enrollees for Lifesaving Research

health prnewswire_all 5/18/2026
Decades of Neglect Leaves Millions of People with COPD at Risk--National COPD Leaders Call for Urgent Policy Action

Decades of Neglect Leaves Millions of People with COPD at Risk--National COPD Leaders Call for Urgent Policy Action

health prnewswire_all 5/18/2026
Luminex Multiplex Assays Market Projected to Reach USD 3.89 Billion by 2033, Driven by Rising Demand for High-Throughput Biomarker Profiling and Standardized Multiplex Testing Workflows: Verified Market Research

Luminex Multiplex Assays Market Projected to Reach USD 3.89 Billion by 2033, Driven by Rising Demand for High-Throughput Biomarker Profiling and Standardized Multiplex Testing Workflows: Verified Market Research

health prnewswire_all 5/18/2026
Staggered international hiring helps healthcare systems build reliable workforce pipelines

Staggered international hiring helps healthcare systems build reliable workforce pipelines

hyre.in
health prnewswire_all 5/18/2026
In HelloNation, Hospice Care Expert Cindy Mensik of Texas City, TX, Highlights the Differences Between Hospice & Home Health Care

In HelloNation, Hospice Care Expert Cindy Mensik of Texas City, TX, Highlights the Differences Between Hospice & Home Health Care

health prnewswire_all 5/18/2026
Global Radiopharmaceuticals Market Set for Significant Expansion at a CAGR of ~10% by 2034 with Increasing Adoption of Targeted Radiotherapy | DelveInsight

Global Radiopharmaceuticals Market Set for Significant Expansion at a CAGR of ~10% by 2034 with Increasing Adoption of Targeted Radiotherapy | DelveInsight

health prnewswire_all 5/18/2026
Coastal Medical Transportation Systems Announces Acquisition of Alert Ambulance, Continues Expansion of Regional Care Network

Coastal Medical Transportation Systems Announces Acquisition of Alert Ambulance, Continues Expansion of Regional Care Network

health prnewswire_all 5/18/2026
Bambusa Therapeutics Presents Positive Preliminary Phase 1 BBT002 Data at American Thoracic Society 2026 (ATS 2026) International Conference and Announces First Patient Dosed in Phase 1b/2a CRSwNP Trial

Bambusa Therapeutics Presents Positive Preliminary Phase 1 BBT002 Data at American Thoracic Society 2026 (ATS 2026) International Conference and Announces First Patient Dosed in Phase 1b/2a CRSwNP Trial

health prnewswire_all 5/18/2026
SKINformed Leads the Rise of "Clean Clinical" Skincare -- Where Medical-Grade Science Meets Clean, Safe Ingredients

SKINformed Leads the Rise of "Clean Clinical" Skincare -- Where Medical-Grade Science Meets Clean, Safe Ingredients

health prnewswire_all 5/18/2026
VIO Med Spa Adds 10 New Franchise Owners Across Key U.S. Markets

VIO Med Spa Adds 10 New Franchise Owners Across Key U.S. Markets

health prnewswire_all 5/18/2026
Continental Senior Communities Expands Tenera Care Partnership Following Breakthrough Success at Dublin Glenn

Continental Senior Communities Expands Tenera Care Partnership Following Breakthrough Success at Dublin Glenn

aiku.in
health prnewswire_all 5/18/2026
Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics

Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics

health prnewswire_all 5/18/2026
MS Pharma anuncia una inversión estratégica para su crecimiento por parte de Olayan Financing Company

MS Pharma anuncia una inversión estratégica para su crecimiento por parte de Olayan Financing Company

aiku.in
health prnewswire_all 5/18/2026
SHARx Calls for Accountability as Policymakers Target PBM Practices Nationwide

SHARx Calls for Accountability as Policymakers Target PBM Practices Nationwide

health prnewswire_all 5/18/2026
FDA Approves IMMGOLIS™ (golimumab-sldi) and IMMGOLIS INTRI™ (golimumab-sldi), First Biosimilars to Simponi® (golimumab) and Simponi Aria® (golimumab); Accord BioPharma to Lead U.S. Commercialization

FDA Approves IMMGOLIS™ (golimumab-sldi) and IMMGOLIS INTRI™ (golimumab-sldi), First Biosimilars to Simponi® (golimumab) and Simponi Aria® (golimumab); Accord BioPharma to Lead U.S. Commercialization

health prnewswire_all 5/18/2026
THE ACADEMY OF GEROSCIENCE WELCOMES SIXTEEN LEADING SCIENTISTS AS NEW MEMBERS

THE ACADEMY OF GEROSCIENCE WELCOMES SIXTEEN LEADING SCIENTISTS AS NEW MEMBERS

health prnewswire_all 5/18/2026
FDA Grants Breakthrough Therapy Designation to VERTANICAL's VER-01, a First-in-Class Non-Opioid Investigational Treatment for Chronic Low Back Pain

FDA Grants Breakthrough Therapy Designation to VERTANICAL's VER-01, a First-in-Class Non-Opioid Investigational Treatment for Chronic Low Back Pain

health globenewswire_business 5/18/2026
CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs

CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs

health prnewswire_all 5/18/2026
Biotheryx Announces Data from its Phase 1 Dose Escalation Study of BTX-9341, a First-in-Class, Potent and Selective CDK4/6 Degrader, for the Treatment of Advanced/Metastatic HR+/HER2- Breast Cancer

Biotheryx Announces Data from its Phase 1 Dose Escalation Study of BTX-9341, a First-in-Class, Potent and Selective CDK4/6 Degrader, for the Treatment of Advanced/Metastatic HR+/HER2- Breast Cancer

health prnewswire_all 5/18/2026
MS Pharma Announces Strategic Growth Investment from Olayan Financing Company

MS Pharma Announces Strategic Growth Investment from Olayan Financing Company

health prnewswire_all 5/18/2026
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX)

Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX)

health prnewswire_all 5/18/2026
Samson Clinical Announces Last Patient Last Visit in its Pivotal Phase III Study of Sublingual Minoxidil for Male Androgenetic Alopecia

Samson Clinical Announces Last Patient Last Visit in its Pivotal Phase III Study of Sublingual Minoxidil for Male Androgenetic Alopecia

health prnewswire_all 5/18/2026
Triveni Bio Doses First Healthy Volunteers with Next-Generation Bispecific Antibody TRIV-573 Targeting Kallikreins 5 & 7 and Interleukin 13 in Phase 1 Clinical Trial

Triveni Bio Doses First Healthy Volunteers with Next-Generation Bispecific Antibody TRIV-573 Targeting Kallikreins 5 & 7 and Interleukin 13 in Phase 1 Clinical Trial

health prnewswire_all 5/18/2026
Triquetra Health Launches Instant Aminos--First Free-Form EAA Tablets Delivering All 9 Essential Amino Acids with Zero Bloating

Triquetra Health Launches Instant Aminos--First Free-Form EAA Tablets Delivering All 9 Essential Amino Acids with Zero Bloating

health prnewswire_all 5/18/2026
Bracco and ACIST Medical Systems Announce U.S. FDA Clearance of ACIST Pro™ Diagnostic System

Bracco and ACIST Medical Systems Announce U.S. FDA Clearance of ACIST Pro™ Diagnostic System